TABLE 1.
Interim analysis | Number of patients with complete follow‐up |
|
|
||
---|---|---|---|---|---|
1 a | 500 | NA | NA | ||
2 | 750 | 0.9984 | 0.1003 | ||
3 | 1000 | 0.9963 | 0.2591 | ||
4 | 1250 | 0.9928 | 0.5411 | ||
Final b | Max 1500 | 0.9875 | NA |
Note: is the stopping boundary for superiority at the i‐th analysis; is the stopping boundary for futility at the i‐th analysis.
Only response adaptive randomization (RAR) was performed at the first interim analysis (i.e., no early stopping for efficacy or futility was permitted).
If the trial did not stop early for efficacy or futility, the final analysis was performed once 1500 patients were recruited and followed up; if the trial stopped early, then the final analysis was performed once the recruited patients completed follow‐up.